CLOV plans sale of 23,463 Class A shares

CLOV discloses a planned sale of 23,463 shares of Class A Common Stock through Morgan Stanley Smith Barney LLC on July 15, 2026 on Nasdaq, with an aggregate market value of $109,806.84.

Rhea-AI Filing Summary

CLOV discloses a planned sale of 23,463 shares of Class A Common Stock through Morgan Stanley Smith Barney LLC on July 15, 2026 on Nasdaq, with an aggregate market value of $109,806.84.

The shares derive from restricted stock units granted by the issuer as compensation and acquired on July 15, 2026. Over the prior three months, 220,426 shares of Class A Common Stock were sold for $879,499.74 under 10b5-1 Plan Sales for Conrad Wai.

Key Figures

Planned shares for sale: 23,463 shares Aggregate market value of planned sale: $109,806.84 Prior 3-month shares sold: 220,426 shares +2 more

5 metrics

Planned shares for sale 23,463 shares Class A Common Stock to be sold on July 15, 2026

Aggregate market value of planned sale $109,806.84 Value of 23,463 Class A shares to be sold

Prior 3-month shares sold 220,426 shares Class A Common Stock sold on May 28, 2026 under 10b5-1 Plan Sales for Conrad Wai

Prior 3-month sale proceeds $879,499.74 Total proceeds from 220,426 shares sold on May 28, 2026

Planned sale date 07/15/2026 Date for sale of 23,463 Class A Common Stock shares

Key Terms

Class A Common Stock, Restricted Stock Units, 10b5-1 Plan Sales

3 terms

Class A Common Stock financial

"Class A Common Stock | Morgan Stanley Smith Barney LLC 1 New York Plaza"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Restricted Stock Units financial

"Class A Common Stock | 07/15/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Plan Sales financial

"10b5-1 Plan Sales for Conrad Wai 1209 Orange Street Wilmington DE 19801"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLOV Class A shares are planned for sale?

The planned sale covers 23,463 shares of Class A Common Stock. These shares have an aggregate market value of $109,806.84 and are expected to be sold on July 15, 2026 through Morgan Stanley Smith Barney LLC on Nasdaq.

What is the source of the CLOV shares being sold?

The 23,463 shares planned for sale come from Restricted Stock Units granted by the issuer as compensation. These units were acquired on July 15, 2026 and are now being converted into Class A Common Stock for sale.

When will the CLOV Class A Common Stock sale occur?

The planned sale date is July 15, 2026. On that date, 23,463 shares of Class A Common Stock are expected to be sold on Nasdaq through Morgan Stanley Smith Barney LLC, according to the disclosed transaction details.

What prior CLOV stock sales were made in the last three months?

Over the past three months, 220,426 shares of CLOV Class A Common Stock were sold for a total of $879,499.74. These transactions are listed as 10b5-1 Plan Sales for Conrad Wai, dated May 28, 2026.

Which broker is handling the planned CLOV share sale?

The planned sale of 23,463 CLOV Class A shares will be handled by Morgan Stanley Smith Barney LLC. The broker’s listed office is at 1 New York Plaza, 8th Floor, New York, NY 10004, with trading to occur on Nasdaq.

What type of CLOV security is involved in the Form 144 notice?

The notice covers Class A Common Stock of CLOV. The shares originate from Restricted Stock Units awarded by the issuer as compensation, which are being converted into common stock for the planned sale on July 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/15/2026 - 05:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001971702
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	Conrad Wai
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	23463	109806.84	430969398	07/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	07/15/2026	Restricted Stock Units	Issuer			23463	07/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Plan Sales for Conrad Wai 1209 Orange Street Wilmington DE 19801	Class A Common Stock	05/28/2026	220426	879499.74

144: Remarks and Signature

Remarks	The proposed sales reported represent shares to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The purpose of the proposed sales is to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the reporting person.
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Peter J. Rivas as attorney-in-fact for Conrad Wai
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)